Reported 1 day ago
Amgen has announced a $900 million expansion of its biotech manufacturing facility in Ohio, increasing its total investment in the region to over $1.4 billion and creating 750 jobs. This move follows recent commitments from other drugmakers to boost U.S. manufacturing in response to potential import tariffs amidst ongoing national security investigations by the Trump administration. Since the 2017 Tax Cuts and Jobs Act, Amgen has invested nearly $5 billion in U.S. capital projects, contributing significantly to the economy.
Source: YAHOO